戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ion loss, despite treatment with topical and systemic steroids.
2 sceration was required in patients receiving systemic steroids.
3  diagnoses but influenza predicted receiving systemic steroids.
4 tases or active autoimmune disease requiring systemic steroids.
5  treat and frequently requires high doses of systemic steroids.
6 mptoms that persisted after being started on systemic steroids.
7 st 6 months, and had had limited exposure to systemic steroids.
8 es is greatest in those men using continuous systemic steroids.
9 treal, systemic, and topical antibiotics and systemic steroids.
10  inflammation resolved following topical and systemic steroids.
11  five (11%) patients with two (5%) requiring systemic steroids.
12      The patient was given a brief course of systemic steroids.
13  usually responds to a course of topical and systemic steroids.
14 ated adverse events requiring treatment with systemic steroids (0.61, 0.46-0.81, p=0.00051), and immu
15 mptomatic; 24 (25.8%) were using therapeutic systemic steroids (16 [67%] of whom were on replacement
16 ients recovered with supportive measures and systemic steroids, 2 fatalities occurred and were attrib
17 dard post-operative medications, a course of systemic steroids (40 mg per day of Prednisolone tablets
18 emale 56.0%) and found 11.8% were prescribed systemic steroids (46.1% parenteral, 47.3% oral, 6.6% bo
19  1.48-41.56], P = .02) and concurrent use of systemic steroids (aHR 5.31 [95% CI 1.18-24.00], P = .03
20 educed the number of exacerbations requiring systemic steroid and the annual exacerbation rate compar
21                                              Systemic steroids and antibiotics should be used in COPD
22                      Medical treatments with systemic steroids and antimetabolites have been tried bu
23                                              Systemic steroids and immunomodulatory agents were succe
24 ses, age at diagnosis, sex, and early use of systemic steroids and methotrexate were significantly as
25 comparing the sixteen patients that received systemic steroids and the sixty-seven that did not; howe
26  as worsening respiratory symptoms requiring systemic steroids and/or antibiotics (moderate to severe
27 had severe respiratory symptoms resistant to systemic steroids, and 1 patient died of severe intersti
28 eived bronchodilators, 59,240 (85%) received systemic steroids, and 59,053 (85%) were given antibioti
29 , hypertension, ascites, bleeding disorders, systemic steroids, and laparoscopic procedures.
30 onotherapy, combination therapy, mesalamine, systemic steroids, and no therapy.
31 itors (SSRIs), monoclonal antibodies (MABs), systemic steroids, and other anti-inflammatory drugs (AD
32 ory symptoms requiring either antibiotics or systemic steroids, and severe events by the need for hos
33 rapies in the form of intravitreal steroids, systemic steroids, and systemic antibiotics were used in
34                                              Systemic steroids are commonly used to manage immune-rel
35                                              Systemic steroids are the first line of therapy for GVHD
36                                              Systemic steroids are the standard first-line treatment
37                                              Systemic steroids are the standard treatment for bronchi
38  disease (GVHD) typically requires high-dose systemic steroids as first-line treatment.
39        Nearly 39% (n = 1326) were prescribed systemic steroids at some point during the analysis peri
40 relate with cystic fibrosis genotype, use of systemic steroids, blood pressure, liver enzymes, C-reac
41 nvasive mechanical ventilation also received systemic steroids, but Black veterans were less likely t
42 edication reconciliation, and categorized as systemic steroids, calcineurin inhibitors, antimetabolit
43                                   The use of systemic steroids does not seem to worsen long-term outc
44 ]; 9394 White patients [76.9%]) who received systemic steroids during ICI treatment and 7942 patients
45                               Intraocular or systemic steroids fail to prevent light-induced photorec
46 vidence and guidelines do not support use of systemic steroids for acute respiratory tract infections
47  postextubation stridor, and be administered systemic steroids for at least 4 hours before extubation
48 I, 1.39-287; P = .03) and those treated with systemic steroids for eye disease (OR, 10.1; 95% CI,1.60
49         Five patients (8%) were treated with systemic steroids for immune-related AEs.
50                     For patients with irAEs, systemic steroids for irAEs were associated with signifi
51 into 3 cohorts: those receiving no steroids, systemic steroids for irAEs, and steroids for non-irAE-a
52 erapy may be considered as an alternative to systemic steroids for treatment of orbital benign lympho
53                Treatment of the patient with systemic steroids healed the skin lesion without improvi
54                         Thus, in addition to systemic steroid hormone cues, forward lineage progressi
55 ons (HR, 1.95; 95% CI, 1.38-2.75) and use of systemic steroids (HR, 3.22; 95% CI, 2.02-5.14).
56 cipants received systemic therapy, including systemic steroids, immunosuppressants, or biologics.
57 urgery, and initiation or dose escalation of systemic steroids, immunosuppressants, small molecules,
58 sed meta-analysis to investigate the role of systemic steroid in the recovery of efferent dysfunction
59 nts received infliximab (n = 40 [87%]), with systemic steroids in 28 cases (61%) and immunosuppressan
60                Treatment included topical or systemic steroids in all cases, with 4 patients (80%) re
61 se of this study was to evaluate the role of systemic steroids in post-procedural endophthalmitis as
62 d if they were taking or expected to receive systemic steroids in the immediate postoperative period
63                                  The role of systemic steroids in the treatment of ophthalmoplegia in
64                              The efficacy of systemic steroids in treating AZOOR has been previously
65                                              Systemic steroid injections are still widely used to tre
66 ssation of topiramate along with topical and systemic steroids is required to prevent serious complic
67 edication for acute and chronic OME, such as systemic steroids, is most likely used globally in an un
68 cus-related ophthalmoplegia (HZORO) in which systemic steroid led to complete resolution of external
69                     Our results suggest that systemic steroids may be much less likely to trigger sev
70 be treated with antimicrobials, and local or systemic steroids may be used depending on the severity
71              Individual response patterns to systemic steroids might be useful in guiding the choice
72          CAPT should be delayed if receiving systemic steroids or antihistamines.
73 cedural endophthalmitis that either received systemic steroids or did not around the time of diagnosi
74 , had no active autoimmune disease requiring systemic steroids or immunosuppressive agents, had no ac
75 teritis, either alone or in combination with systemic steroids or ketotifen.
76 k-back and ceased follow-up at initiation of systemic steroids or oral quinolones, external injury, h
77 n 60 mL per min, treatment for osteoporosis, systemic steroids, or oestrogen-replacement therapy.
78  nutrition, dialysis, surgery, pancreatitis, systemic steroids, or other immunosuppressants).
79 operly and treated with intensive topical or systemic steroids, possibly combined with interface irri
80 vidence-based COVID-19 treatments, including systemic steroids, remdesivir, and immunomodulatory drug
81           Five patients that did not receive systemic steroids required an enucleation or evisceratio
82                  A multidomain evaluation of systemic steroid responsiveness using pragmatic clinical
83  not increase asthma exacerbations requiring systemic steroid therapy and hospitalization.
84 over the roles of surgical decompression and systemic steroid therapy for TON, these interventions ha
85 apy and achieving only moderate success with systemic steroid therapy, he was ultimately treated with
86 core of 1 are candidates for rapid tapers of systemic steroid therapy.
87  systemic antibiotic therapy, and 1 received systemic steroid therapy.
88                    To investigate the use of systemic steroids to treat allergic rhinitis in Denmark
89 icosteroid therapy; however, the efficacy of systemic steroid treatment is under debate and serious a
90 d a previous history of weight gain and 2 of systemic steroid treatment; these can be referred to as
91 7, P = .032]; [beta = -0.44, P = .028]), and systemic steroid use ([beta = -0.066, P = .032]; [beta =
92 ase (AD), chronic infection and pre-existing systemic steroid use (regardless of dose).
93 e to a strong association between continuous systemic steroid use and vertebral fractures: age-adjust
94  Patients were divided according to previous systemic steroid use at onset of pneumonia.
95                 In this study, we found that systemic steroid use in ARTI is common with a great geog
96                       We excluded those with systemic steroid use in the prior year and an extensive
97                    Our analyses suggest that systemic steroid use is associated with site-specific di
98 tes were tested for association with current systemic steroid use using generalized linear mixed mode
99 ate, oxygen use on admission, mental status, systemic steroid use, activities of daily living, and th
100  index, smoking, hypertension, diabetes, and systemic steroid use.
101 ), Inhaled Steroid Users (ISU) (n = 70), and Systemic Steroid Users (SSU) (n = 125).
102 nd sex, and a sensitivity analysis excluding systemic steroid users were performed.
103    For the subsequent 30 procedures (35.3%), systemic steroids were administered intravenously or ora
104 us SCH and greater percent of eyes receiving systemic steroids were associated with greater improveme
105 ral acyclovir, low-dose topical steroids and systemic steroids were started.
106       We calculated the proportion receiving systemic steroids within 7 days of the ARTI diagnosis an

 
Page Top